Market Cap 330.21M
Revenue (ttm) 5.00M
Net Income (ttm) -156.99M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -3,139.76%
Debt to Equity Ratio 0.00
Volume 236,600
Avg Vol 186,692
Day's Range N/A - N/A
Shares Out 41.80M
Stochastic %K 8%
Beta N/A
Analysts Strong Sell
Price Target $32.50

Latest News on ZBIO

Zenas BioPharma Seeks IPO For Inflammatory Treatment Trials

Aug 26, 2024, 11:11 AM EDT - 7 months ago

Zenas BioPharma Seeks IPO For Inflammatory Treatment Trials


Bristol-Myers Squibb-backed Zenas BioPharma files for US IPO

Aug 22, 2024, 3:25 PM EDT - 7 months ago

Bristol-Myers Squibb-backed Zenas BioPharma files for US IPO


Zenas BioPharma IPO Registration Document (S-1)

Aug 22, 2024, 2:41 PM EDT - 7 months ago

Zenas BioPharma IPO Registration Document (S-1)